Saganuwan Alhaji Saganuwan | Oncology | Editorial Board Member

Innovative Research Award

Saganuwan Alhaji Saganuwan · Usmanu Danfodiyo University Sokoto · Nigeria

Researcher profile
Saganuwan Alhaji Saganuwan
Affiliation Usmanu Danfodiyo University Sokoto
Country Nigeria
Scopus ID 59967569100
Documents 52
Citations 548
h-index 12
Subject Area Oncology
Event Genetics Awards
ORCID Not provided

The Innovative Research Award is a research recognition category intended to highlight scientific inquiry, scholarly contributions, and the potential impact of research across relevant disciplines. This profile presents Saganuwan Alhaji Saganuwan in connection with the Genetics Awards event, with oncology identified as the subject area and Usmanu Danfodiyo University Sokoto in Nigeria listed as the institutional affiliation. The bibliometric figures supplied for this profile are 52 documents, 548 citations, and an h-index of 12. These indicators provide a quantitative snapshot of the research record but do not independently establish research quality, clinical impact, or award eligibility.

Abstract

This article provides an academic recognition profile for Saganuwan Alhaji Saganuwan in the context of the Innovative Research Award associated with Genetics Awards. The supplied profile identifies oncology as the subject area and Usmanu Danfodiyo University Sokoto as the institutional affiliation. Reported bibliometric indicators include 52 documents, 548 citations, and an h-index of 12. These figures are presented as user-supplied information and should be checked against the researcher’s current Scopus author record before publication. Detailed biographical information, specific research findings, a verified publication list, and an award-specific evaluation have not been supplied; accordingly, this profile avoids attributing particular discoveries or achievements without supporting documentation.

Keywords

Innovative Research Award; Saganuwan Alhaji Saganuwan; oncology; cancer research; scholarly publications; bibliometrics; research impact; scientific recognition; Genetics Awards; Nigeria.

Introduction

Research awards can provide a formal setting for recognizing scholarly work, methodological development, and contributions to the advancement of scientific knowledge. In biomedical research, oncology encompasses the study of cancer biology, prevention, diagnosis, treatment, and outcomes. Evaluating a researcher’s contribution in this field requires consideration of the relevance and reliability of the published work, the strength of the evidence, and its contribution to the wider literature.

This article summarizes the information supplied for Saganuwan Alhaji Saganuwan’s research recognition profile. It distinguishes reported bibliometric indicators from independently verified evidence and does not infer specific research findings, professional appointments, or award decisions from citation metrics alone. General guidance on interpreting research indicators is available from the Leiden Manifesto and the San Francisco Declaration on Research Assessment (DORA). [1] [2]

Research Profile

The information provided identifies Saganuwan Alhaji Saganuwan with Usmanu Danfodiyo University Sokoto, Nigeria, and lists oncology as the subject area for this recognition profile. The associated Scopus author identifier is presented as 59967569100. Scopus author profiles can be used to examine indexed publications, citation records, and related bibliometric information, although author-name matching and record coverage should be reviewed before these data are treated as definitive. [3]

A comprehensive scholarly profile would normally include the researcher’s education, current and previous appointments, principal research questions, methodological expertise, collaborative work, and selected publications. These details were not included in the supplied input and are therefore not asserted here. The researcher’s ORCID identifier was also not provided.

Profile field Information supplied
Researcher Saganuwan Alhaji Saganuwan
Institution Usmanu Danfodiyo University Sokoto
Country Nigeria
Subject area Oncology
Documents 52 (reported)
Citations 548 (reported)
h-index 12 (reported)

Research Contributions

Research contributions in oncology may include advances in understanding disease mechanisms, the development or evaluation of diagnostic approaches, investigations of therapeutic efficacy and safety, studies of cancer epidemiology, and research into patient outcomes. The relevance of any particular contribution must be assessed using the underlying publications and supporting evidence.

The supplied information does not identify specific projects, experimental findings, clinical studies, patents, guidelines, or policy contributions attributable to Saganuwan Alhaji Saganuwan. Therefore, no individual discovery or clinical outcome is assigned to the researcher in this section. A complete version should include verified examples of relevant work and explain their original contribution, methods, limitations, and significance within the field.

  • Identify peer-reviewed studies directly associated with the researcher’s verified author profile.
  • Summarize the research question, study design, principal findings, and limitations of each selected study.
  • Document evidence of influence, such as independent citations, follow-up studies, clinical relevance, or adoption of research methods.

Publications

The supplied information reports 52 documents associated with the research profile. A complete bibliography cannot be reliably reconstructed from this aggregate number alone. Publication titles, author lists, journal details, publication dates, and digital object identifiers (DOIs) should be checked against the indexed records and the original publisher pages before individual papers are listed.

For publication verification, consult the Scopus author record and compare relevant entries with publisher websites or Crossref metadata. [3] No individual DOI is asserted in this article because a verified publication-specific DOI was not supplied.

  1. Compile the verified publication list from the researcher’s indexed record.
  2. Check author identity, article title, journal, year, volume, issue, and page or article number against the publisher’s record.
  3. Include DOI links only after confirming that each DOI resolves to the stated publication.

Research Impact

The supplied profile reports 548 citations across 52 documents and an h-index of 12. The h-index is a bibliometric indicator reflecting a combination of publication productivity and citation frequency; it does not directly measure methodological rigor, originality, societal benefit, or clinical effectiveness. Citation totals and h-index values may differ between databases because of their coverage, author disambiguation, update schedules, and citation-counting practices. [1] [2]

Indicator Reported value Interpretation
Documents 52 Reported publication count; database coverage and author matching require verification.
Citations 548 Reported citations; counts may change over time and vary across databases.
h-index 12 A combined measure of publication output and citation distribution.

These figures should be accompanied by a retrieval date and database attribution in a final published profile. A balanced assessment should also consider research quality, contribution to collaborative papers, reproducibility, relevance to the field, and evidence of wider use rather than relying exclusively on quantitative indicators.

Award Suitability

The Innovative Research Award profile identifies Saganuwan Alhaji Saganuwan, an affiliation with Usmanu Danfodiyo University Sokoto, Nigeria, and oncology as the stated subject area. The reported publication and citation indicators can serve as supporting information during an award review, provided they are independently verified and interpreted in context.

A defensible award assessment would require evidence that the nominee’s work satisfies the published criteria of the awarding organization. Relevant evidence could include original research contributions, peer-reviewed publications, research methods, documented influence on subsequent scholarship, interdisciplinary collaboration, and demonstrated scientific or societal relevance. Bibliometric measures alone are insufficient to establish that a nominee meets these criteria. [2]

Accordingly, this article presents an informational recognition profile rather than a verified award decision or an independent determination of eligibility. The event name supplied is Genetics Awards; the official award category, nomination status, selection outcome, and evaluation criteria should be confirmed with the event organizer before publication.

Conclusion

This academic recognition profile records the supplied details for Saganuwan Alhaji Saganuwan, including the stated institutional affiliation, country, subject area, and bibliometric indicators. The reported values of 52 documents, 548 citations, and an h-index of 12 provide a starting point for examining the research record, but they require verification against the relevant database. A fuller scholarly article should incorporate confirmed biographical details, representative publications, publication-specific DOI links, documented research findings, and transparent evidence relevant to the award criteria. This approach supports accurate academic communication while avoiding unsupported claims about achievements or award outcomes.

References

  1. Hicks, D., Wouters, P., Waltman, L., de Rijcke, S., & Rafols, I. (2015). Bibliometrics: The Leiden Manifesto for research metrics. Nature, 520, 429–431. https://doi.org/10.1038/520429a.
  2. San Francisco Declaration on Research Assessment (DORA). (2012; subsequently maintained online). Declaration and recommendations concerning the responsible use of research assessment metrics. https://sfdora.org/.
  3. Elsevier. Scopus. Author search and bibliographic database. The researcher identifier supplied for this profile is 59967569100; author attribution and bibliometric values should be confirmed directly in the database. Scopus author record.

Alesia Tietze | Medicinal Chemistry in Cancer | Innovative Research Award

Innovative Research Award

Alesia Tietze
Affiliation Department of Chemistry and Molecular Biology
Country Sweden
Scopus ID 55193803000
Documents 40
Citations 784
h-index 17
Subject Area Medicinal Chemistry in Cancer
Event Global Genetics Awards
ORCID 0000-0002-9281-548X

Alesia Tietze
Department of Chemistry and Molecular Biology

Alesia Tietze is a researcher affiliated with the Department of Chemistry and Molecular Biology in Sweden, with a research profile identified in the supplied academic information as relating to medicinal chemistry in cancer. The profile is associated with 40 Scopus-indexed documents, 784 citations, and an h-index of 17. These bibliometric indicators provide a quantitative view of research visibility and scholarly impact, while the award assessment itself should be based on the complete research record and independently verified evidence. [3]

Abstract

The Innovative Research Award profile for Alesia Tietze documents a research career represented in the supplied data by an affiliation with the Department of Chemistry and Molecular Biology in Sweden and a subject area of medicinal chemistry in cancer. The associated Scopus record is reported as containing 40 documents, 784 citations, and an h-index of 17. [1] These metrics can be used as supporting indicators of scholarly activity and citation reach, but they do not independently establish the novelty, methodological quality, translational significance, or originality of individual research contributions. The researcher is also associated with an ORCID identifier, providing a persistent identifier for distinguishing the scholarly record. [2]

Keywords

Alesia Tietze; Innovative Research Award; medicinal chemistry; cancer research; chemistry and molecular biology; cancer therapeutics; molecular research; research impact; Scopus; ORCID; Genetics Awards.

Introduction

Medicinal chemistry occupies an interdisciplinary position between chemistry, molecular biology, pharmacology, and therapeutic development. Research in this area may involve the design, synthesis, characterization, optimization, and biological evaluation of compounds intended to address disease-associated molecular targets. In cancer research, medicinal chemistry can intersect with studies of molecular mechanisms, therapeutic targets, biomarkers, drug resistance, and precision-oriented treatment strategies.

Within this broad research environment, academic recognition generally requires consideration of both quantitative and qualitative evidence. Bibliometric indicators such as document counts, citation counts, and h-index values can provide useful measures of scholarly visibility, while publications, methodological contributions, collaborations, and demonstrable scientific outcomes provide additional context. The Genetics Awards program states that submitted research profiles may undergo screening, credential verification, cross-checking of submitted information, and committee review before selection. [3]

Research Profile

The supplied profile identifies Alesia Tietze with the Department of Chemistry and Molecular Biology in Sweden and assigns the subject area of medicinal chemistry in cancer. The reported Scopus information comprises 40 documents, 784 citations, and an h-index of 17. [1] Taken together, these values indicate a documented body of indexed scholarly output and citation activity.

The research profile should be interpreted in relation to the underlying publications rather than as a standalone ranking. Citation indicators can vary according to database coverage, publication type, disciplinary citation practices, author disambiguation, and the date on which the record is consulted. The ORCID identifier supplied for the researcher offers an additional mechanism for connecting scholarly outputs to a persistent researcher identity. [2]

Research Contributions

Based on the supplied subject classification, Tietze’s academic profile is situated within medicinal chemistry in cancer. This field encompasses research that connects chemical science with biological and therapeutic questions relevant to oncology. The precise contribution of an individual researcher should, however, be established from verified publications, research projects, patents, datasets, collaborations, and other primary scholarly evidence rather than inferred solely from a subject-area label.

For an award evaluation, relevant evidence may include the originality of research questions, rigor of experimental or computational methods, reproducibility, significance of findings, contribution to interdisciplinary research, and potential relevance to cancer biology or therapeutic development. The Genetics Awards program identifies research excellence and related scientific contributions among the areas considered within its award framework. [3]

Publications

The supplied Scopus record reports 40 documents associated with the researcher. [1] Because individual publication titles, journals, publication years, authorship positions, and DOI identifiers were not supplied in the source information for this profile, specific publications are not enumerated here. This avoids attributing research findings or bibliographic details that have not been independently established.

For formal award documentation, the publication record can be verified through the researcher’s Scopus author profile and persistent ORCID identifier. Where individual publications are evaluated, DOI metadata should be checked against the publisher or DOI registration record before being included in a nomination dossier.

Research Impact

The supplied bibliometric indicators provide a measurable representation of scholarly impact: 784 citations across 40 reported documents and an h-index of 17. [1] These indicators may support an assessment of sustained research visibility, but they should be interpreted alongside publication quality, contribution to the scientific literature, collaboration, methodological innovation, and the broader significance of the research.

In the context of cancer-focused medicinal chemistry, research impact may also be considered through the extent to which scientific findings contribute to understanding disease mechanisms, identifying therapeutic opportunities, improving molecular tools, or informing subsequent research. Such outcomes require evidence from the underlying scholarly record and should not be inferred solely from citation statistics.

Award Suitability

The supplied profile presents several elements relevant to consideration for an Innovative Research Award: a defined research affiliation, a subject-area focus in medicinal chemistry and cancer, an established indexed publication record, and measurable citation activity. The reported h-index of 17 and 784 citations may serve as supporting bibliometric evidence of scholarly reach. [1]

Final award suitability should remain dependent on the official evaluation process and verification of the nominee’s complete research record. The Genetics Awards program describes a process involving submission screening, verification of credentials, cross-checking of information, committee review, and subsequent selection. [3] Accordingly, the present article should be understood as an academic recognition profile based on the supplied information rather than as an independent declaration of award selection.

Conclusion

Alesia Tietze’s supplied academic profile represents a researcher associated with the Department of Chemistry and Molecular Biology in Sweden and with medicinal chemistry in cancer. The reported Scopus indicators of 40 documents, 784 citations, and an h-index of 17 provide quantitative evidence of an established scholarly record. [1] The associated ORCID identifier further supports persistent scholarly identification. [2]

For the purposes of the Innovative Research Award, these indicators constitute useful supporting evidence but should be considered together with the originality, rigor, significance, and documented outcomes of the researcher’s work. A complete assessment should rely on verified publications and other primary academic evidence in accordance with the award’s stated evaluation procedures. [3]

References

  1. Elsevier. (n.d.). Scopus author details: Alesia Tietze, Author ID 55193803000.

    Scopus.https://www.scopus.com/authid/detail.uri?authorId=55193803000

  2. ORCID. (n.d.). ORCID record: Alesia Tietze, ORCID iD 0000-0002-9281-548X.
    https://orcid.org/0000-0002-9281-548X
  3. Targeted sortase A inhibition by novel peptidomimetic antivirulents against staphylococcal infections

    https://pubmed.ncbi.nlm.nih.gov/41773879/

  4. DNA Scission by Non-Histidine Amino-Terminal Cu(II) and Ni(II) Binding-Like Peptides

    https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.70397

Zailin Chen | Lung Cancer | Best Researcher Award

Dr. Zailin Chen | Lung Cancer | Best Researcher Award

Yunnan Land and Resources Vocational College | China

Author Profile

Scopus

🌏 ZAILIN CHEN: PIONEER IN EARTH AND PLANETARY SCIENCES

EARLY ACADEMIC PURSUITS 🎓

Zailin Chen began his academic journey with a strong foundation in Earth and Planetary Sciences, showcasing an early passion for understanding the complexities of the planet. He pursued higher education in prestigious Chinese institutions, specializing in geoscience and planetary studies. His formative years were marked by exceptional academic performance and a clear inclination toward research in geology and planetary systems.

PROFESSIONAL ENDEAVORS 🏛️

Zailin Chen has served as a vital academic and researcher at two renowned institutions:

  1. Yunnan Land and Resources Vocational College, where he has contributed significantly to advancing practical and applied geoscience education.
  2. College of Earth and Planetary Sciences, Chengdu University of Technology, a hub for cutting-edge research in Earth sciences, where Chen continues to excel in combining teaching and research.

His work bridges academia and applied science, with a focus on training future leaders in geology and resource management.

CONTRIBUTIONS AND RESEARCH FOCUS ON LUNG CANCER 🌋

Zailin Chen’s research is centered on:

  • The exploration and sustainable management of Earth’s natural resources.
  • Advanced studies in planetary geology, contributing to the understanding of terrestrial planets.
  • Innovations in geotechnical applications and environmental management.

His publications often reflect groundbreaking insights into Earth’s geological processes and their planetary parallels.

IMPACT AND INFLUENCE 🌟

Through his work, Zailin Chen has made a lasting impact on both academia and the practical applications of Earth sciences. His contributions have influenced policies on natural resource management and advanced the understanding of geological phenomena. As a mentor, he has guided countless students, fostering a new generation of geoscientists.

ACADEMIC CITATIONS 📚

Zailin Chen’s research has been well-cited in scientific literature, a testament to the significance of his findings in Earth and Planetary Sciences. His H-index and citation metrics underline his influence in the academic community.

LEGACY AND FUTURE CONTRIBUTIONS 🚀

Zailin Chen’s legacy lies in his dual impact on theoretical and applied geosciences. Looking forward, he aims to expand his research into interdisciplinary fields such as environmental geoscience and planetary exploration, further cementing his role as a global thought leader in Earth sciences.

NOTABLE PUBLICATIONS 📑

"Pollution level and distribution characteristics of heavy metals and microplastics in the soils from the Qionghai Lake Wetland, Southwest China" 

  • Authors: Wang, J. , Chen, Z. , Wang, X. , Shi, H. , Huang, Y.
  • Journal: Gondwana Research
  • Year: 2024

"Identification of core carcinogenic elements based on the age-standardized mortality rate of lung cancer in Xuanwei Formation coal in China" 

  • Authors: Chen, Z. , Cheng, X. , Wang, X. , Yu, Q. , Hu, J.
  • Journal: Scientific Reports
  • Year: 2024

"Adsorption and Immobilization of Cadmium by an Iron-Coated Montmorillonite Composite" 

  • Authors: Ren, B. , Shu, C. , Chen, Z. , Xiao, Q. , He, Y.
  • Journal: Water (Switzerland)
  • Year: 2024

"Evaluation of Contamination and Ecological and Health Risk in Surface Soil and Crops Contaminated with Metalloids and Heavy Metals in Datun, China, “The World Tin Capital" 

  • Authors: Cheng, X. , Chen, Z. , Zhou, X. , Hou, M. , Xiong, J.
  • Journal: Soil and Sediment Contamination
  • Year: 2024

"Origin, formation, and transformation of different forms of silica in Xuanwei Formation coal, China, and its' emerging environmental problem" 

  • Authors: Chen, Z. , Shi, Z. , Ni, S. , Ren, B. , Hu, J.
  • Journal: Environmental science and pollution research international
  • Year: 2023